Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-05

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SARS-CoV-2 is the coronavirus responsible for developing the disease known as COVID-19. Its evolution can range from an asymptomatic course, to rapidly evolve and cause an acute respiratory syndrome. In addition to respiratory symptoms, is also has an impact on the neuromuscular systems. Therefore, the additional inactivity for hospitalization, negatively influences the loss of muscular, cardiovascular and metabolic fitness. In view of this, it is recommended that early post-acute rehabilitation be continued after the hospital phase to increase levels of physical activity, which can also be continued with long-term telerehabilitation.

This project would offer a free service of asynchronous physical telerehabilitation for the patient that is easy to implement and follow up.

For this purpose, patients will be recruited at the time of discharge from the Hospital Provincial Nuestra Señora de Gracia (HPNSG) and the Hospital Royo Villanova (HRV) in Zaragoza and two intervention groups with the same physical therapy and educational programme will be carried out. The experimental group will be carried out by means of home telerehabilitation, while the control group will receive the programme in an explanatory booklet.

The main objective is to analyse the preliminary efficacy on physical fitness of a 12-week physical therapy and therapeutic education programme using asynchronous telerehabilitation in post-COVID-19 patients, and to compare its effects with patients who have undergone the same programme, but in a non-telematic format.

The secondary objective is to analyze the feasibility of a physical home-based asynchronous telerehabilitation programme in post-COVID-19 patients.

Hypothesis: the implementation of a 12-week programme of physical therapy and therapeutic education using asynchronous telerehabilitation software is feasible and preliminarily effective in increasing physical fitness as well as adherence to treatment, and in the improvement of psychosocial factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rehabilitation Program for the Sequelae of COVID 19 Infection

NCT04852718

Covid19

UNKNOWN

Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors

NCT04767477

Covid19 Exercise Tolerance Quality of Life +2 more

COMPLETED NA

Tele-rehabilitation Program After Hospitalization for COVID-19

NCT04821934

COVID-19 Pneumonia

COMPLETED NA

Robotic Assisted Hand Rehabilitation Outcomes in Adults After COVID-19

NCT06137716

Robotic Exoskeleton Post-acute Covid-19 Syndrome Rehabilitation Outcome +1 more

COMPLETED NA

Telerehabilitation in the Post-COVID-19 Patient (TRIALS)

NCT05739552

Post-COVID-19 Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At the first phase, an observational study aims to investigate the physical and psychological status of patients after hospital discharge.

At the second phase, a feasibility pilot study with a single-blinded randomized clinical trial design with volunteer patients admitted to hospital and recruited at the time of discharge by COVID-19 will evaluate a physiotherapy programme. There will be an intervention group (asynchronous telerehabilitation at home) and a control group (home rehabilitation by means of an explanatory leaflet). The intervention will be carried out for 12 weeks with a follow-up at 3 and 6 months.

Intervention:

The physical rehabilitation programme will be designed with three levels of intensity of aerobic, strength and respiratory exercises, and a list of recommendations for self-management of the sequelae of the COVID-19.

The intervention will last for a total of 12 weeks at home (three days a week for 45-60 minutes a day) with a biweekly phone check-up.

All patients will be provided with the same physical rehabilitation and educational programme, with each allocation group differing in the format of the prescription.

Experimental group

A programme with exercise videos and health recommendations will be prescribed through a telerehabilitation platform to improve fatigue and fitness resulting from COVID-19. The application will be installed on patients' mobile phones and its use will be explained to them so that they can carry out the programme from their homes.

Control group The control group will receive a paper booklet with clear pictures and descriptions of the exercise and educative programme to improve fatigue and fitness.

Assessment:

Fatigue will be assessed with the fatigue severity scale (FSS). Functional capacity will be measured through operation: with the Post-COVID Functional Status Scale (PCFS), the strength with the 30" sit-to-stand (STST), the 30" arm curl test (ACT), and through aerobic capacity with de six minutes walking test (6MWT).

Psychosocial factors will be measured with the general self-efficacy scale (GSES), the depression and anxiety scale (DASS-21), the behavioral regulation questionnaire in sport (BRSQ) and the multidimensional scale of perceived social support (MSPSS).

Quality of life will be measured with the quality of life scale (SF-12).

Adherence and engagement be measured by diary recording and satisfaction with a brief interview.

Outcome measures:

Fatigue, functional status post-COVID-19, strength, aerobic capacity, anxiety and depression, behavior in sport, perceived social support and quality of life will be evaluated before intervention, after intervention (12 weeks) at 3 and 6 months for follow-up.

Adherence and satisfaction will be evaluated after intervention (12 weeks) and during intervention (each 15 days).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus Fatigue Musculoskeletal Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

Telerehabilitation asynchronous programme at home

Group Type EXPERIMENTAL

Asynchronous telerehabilitation programme

Intervention Type OTHER

Home-based physical rehabilitation programme using a telerehabilitation platform

Control Group

Rehabilitation programme with an explanatory booklet at home

Group Type ACTIVE_COMPARATOR

Rehabilitation programme

Intervention Type OTHER

Home-based physical rehabilitation programme by means of an explanatory booklet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Asynchronous telerehabilitation programme

Home-based physical rehabilitation programme using a telerehabilitation platform

Intervention Type OTHER

Rehabilitation programme

Home-based physical rehabilitation programme by means of an explanatory booklet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age range 18-75 years.
* Patients who have been hospitalized for more than 5 days for COVID-19.
* Patients who have been discharged from the hospital and present a fatigue score higher than 4 points on average on the fatigue severity scale (FSS).
* Independent walking, even with the use of any technical aid.
* Have signed the informed consent form.

Exclusion Criteria

* Patients with central and/or peripheral neurological diseases that prevent the programme from being followed.
* Patients with rheumatic pathology or acute musculoskeletal injury in their medical history.
* Patients with severe respiratory failure: SaO2 less than 90% or respiratory rate \>30.
* Patients with cardiac comorbidities or signs of cardiovascular inestability as uncontrolled arrythmia, blood pressure and/or effort angina.
* Patients with other contraindicated pathology for moderate-intensity aerobic or strength exercise.
* Patients without access to mobile internet or computer with internet at home.
* Patients with a score ≤24 on the Mini-Cognitive Examination (MEC).
* Patients who are unable to follow oral and written instructions in Spanish.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No